Subscribe To
SLNO / Why Shares of Soleno Therapeutics Are Booming on Tuesday
SLNO News
By The Motley Fool
September 27, 2023
Why Shares of Soleno Therapeutics Dropped on Wednesday
Soleno announced on Tuesday top-line results for its lead therapy candidate. The company said it plans to submit a New Drug Application to the FDA reg more_horizontal
By Barrons
September 27, 2023
Soleno Stock Dives After Its Meteoric Rise
The biotechnology company had announced positive study results for its DCCR tablets on Tuesday. more_horizontal
By Zacks Investment Research
September 27, 2023
Soleno (SLNO) Soars as Prader-Willi Syndrome Study Meets Goal
Soleno's (SLNO) shares rally as the late-stage study evaluating diazoxide choline for patients with Prader-Willi syndrome meets its primary and second more_horizontal
By The Motley Fool
September 26, 2023
Why Shares of Soleno Therapeutics Are Booming on Tuesday
Soleno specializes in treating rare metabolic disorders. The company's lead therapy, DCCR, fared well as a treatment for Prader-Willi syndrome. more_horizontal
By Zacks Investment Research
January 13, 2023
Soleno Therapeutics, Inc. (SLNO) Upgraded to Strong Buy: What Does It Mean for the Stock?
Soleno Therapeutics, Inc. (SLNO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank more_horizontal
By InvestorPlace
December 19, 2022
Why Is Soleno Therapeutics (SLNO) Stock Up 130% Today?
Though clinical-stage biopharmaceutical firm Soleno Therapeutics (NASDAQ: SLNO ) encountered more than its fair share of setbacks this year, it blitze more_horizontal
By PennyStocks
December 19, 2022
Penny Stocks To Buy Now? 6 To Watch With Big News Today
Hot penny stocks to watch with big news this week. The post Penny Stocks To Buy Now? more_horizontal